476 related articles for article (PubMed ID: 27168870)
1. Hepatocellular carcinoma and the risk of occupational exposure.
Rapisarda V; Loreto C; Malaguarnera M; Ardiri A; Proiti M; Rigano G; Frazzetto E; Ruggeri MI; Malaguarnera G; Bertino N; Malaguarnera M; Catania VE; Di Carlo I; Toro A; Bertino E; Mangano D; Bertino G
World J Hepatol; 2016 May; 8(13):573-90. PubMed ID: 27168870
[TBL] [Abstract][Full Text] [Related]
2. Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).
Ledda C; Loreto C; Zammit C; Marconi A; Fago L; Matera S; Costanzo V; Fuccio Sanzà G; Palmucci S; Ferrante M; Costa C; Fenga C; Biondi A; Pomara C; Rapisarda V
Mol Med Rep; 2017 Feb; 15(2):511-533. PubMed ID: 28000892
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hepatocellular carcinoma in India.
Kar P
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma: the high-risk patient.
Nissen NN; Martin P
J Clin Gastroenterol; 2002; 35(5 Suppl 2):S79-85. PubMed ID: 12394210
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma in Asia: A Challenging Situation.
Jafri W; Kamran M
Euroasian J Hepatogastroenterol; 2019; 9(1):27-33. PubMed ID: 31988864
[TBL] [Abstract][Full Text] [Related]
6. Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
Chen TC; Hsiao SW; Chen YY; Yen HH; Su WW; Hsu YC; Huang SP; Su PY
Sci Rep; 2024 Apr; 14(1):9068. PubMed ID: 38643245
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
Fan JG; Farrell GC;
J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
[TBL] [Abstract][Full Text] [Related]
8. Risk of hepatocellular carcinoma in workers exposed to chemicals.
Uccello M; Malaguarnera G; Corriere T; Biondi A; Basile F; Malaguarnera M
Hepat Mon; 2012 Oct; 12(10 HCC):e5943. PubMed ID: 23162599
[TBL] [Abstract][Full Text] [Related]
9. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease.
Tan YW; Wang JM; Zhou XB
World J Hepatol; 2023 Feb; 15(2):237-254. PubMed ID: 36926239
[TBL] [Abstract][Full Text] [Related]
10. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
Haider MB; Al Sbihi A; Chaudhary AJ; Haider SM; Edhi AI
World J Hepatol; 2022 Sep; 14(9):1804-1816. PubMed ID: 36185720
[TBL] [Abstract][Full Text] [Related]
11. Obesity and hepatocellular carcinoma.
Caldwell SH; Crespo DM; Kang HS; Al-Osaimi AM
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S97-103. PubMed ID: 15508109
[TBL] [Abstract][Full Text] [Related]
12. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
Starley BQ; Calcagno CJ; Harrison SA
Hepatology; 2010 May; 51(5):1820-32. PubMed ID: 20432259
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
Doycheva I; Zhang T; Amjad W; Thuluvath PJ
J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
[TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinoma.
Satarug S
Curr Drug Metab; 2012 Mar; 13(3):257-71. PubMed ID: 22455552
[TBL] [Abstract][Full Text] [Related]
16. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.
Shiani A; Narayanan S; Pena L; Friedman M
Cancer Control; 2017; 24(3):1073274817729240. PubMed ID: 28975833
[TBL] [Abstract][Full Text] [Related]
17. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.
Bacigalupo ML; Manzi M; Rabinovich GA; Troncoso MF
World J Gastroenterol; 2013 Dec; 19(47):8831-49. PubMed ID: 24379606
[TBL] [Abstract][Full Text] [Related]
19. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Cernea S; Onișor D
World J Gastroenterol; 2023 Jan; 29(2):286-309. PubMed ID: 36687124
[TBL] [Abstract][Full Text] [Related]
20. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
Bugianesi E; Leone N; Vanni E; Marchesini G; Brunello F; Carucci P; Musso A; De Paolis P; Capussotti L; Salizzoni M; Rizzetto M
Gastroenterology; 2002 Jul; 123(1):134-40. PubMed ID: 12105842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
